WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011149601) TREATMENT OF VAGALLY- MEDIATED SPECTRUM DISORDERS WITH 5HT3 ANTAGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/149601    International Application No.:    PCT/US2011/032538
Publication Date: 01.12.2011 International Filing Date: 14.04.2011
IPC:
A61K 31/00 (2006.01), A61K 31/4164 (2006.01), A61K 31/4178 (2006.01), A61K 31/4184 (2006.01), A61K 31/437 (2006.01), A61K 31/439 (2006.01), A61K 31/46 (2006.01), A61P 3/04 (2006.01), A61P 11/06 (2006.01), A61P 9/12 (2006.01), A61P 1/04 (2006.01), A61P 25/30 (2006.01), A61P 25/18 (2006.01), A61P 25/28 (2006.01), A61P 25/04 (2006.01)
Applicants: AVMEDIS LLC [US/US]; 975 Pinecrest Drive Sugar Grove, IL 60554-9248 (US) (For All Designated States Except US).
KELBE, Peter, W. [US/US]; (US) (For US Only)
Inventors: KELBE, Peter, W.; (US)
Agent: KEYES, William John; Klintworth & Rozenblat IP LLC 850 West Jackson Boulevard, Suite 660 Chicago, IL 60607 (US)
Priority Data:
13/040,122 03.03.2011 US
61/347,601 24.05.2010 US
Title (EN) TREATMENT OF VAGALLY- MEDIATED SPECTRUM DISORDERS WITH 5HT3 ANTAGONISTS
(FR) TRAITEMENT DE TROUBLES DU SPECTRE À MÉDIATION VAGALE PAR DES ANTAGONISTES DE 5HT3
Abstract: front page image
(EN)The present invention provides a treatment of a vagally-mediated spectrum disorder, comprising administering an effective amount of a 5-HT3 receptor antagonist to a patient in need thereof.
(FR)La présente invention concerne un traitement d'un trouble du spectre à médiation vagale qui comporte l'administration, à un patient qui en a besoin, d'une quantité efficace d'un antagoniste du récepteur 5-HT3.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)